Friday, 26 January 2018

FDA approves drug for rare cancer that killed Steve Jobs

(Reuters) - The U.S. Food and Drug Administration on Thursday approved a therapy for a rare type of digestive tract cancer that killed Apple co-founder Steve Jobs in 2011.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)